castanospermine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradfute, SB; Clarke, EC; Nofchissey, RA; Ye, C | 1 |
1 other study(ies) available for castanospermine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication.
Topics: 1-Deoxynojirimycin; Animals; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Glycoside Hydrolase Inhibitors; Humans; Indolizines; SARS-CoV-2; Vero Cells; Virus Replication | 2021 |